| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Announces Intent to Repurchase up to $500 Million of Its Stock
Ecolab Inc. today closed on the sale of its global surgical solutions business to Medline for total consideration of approximately $950 million in cash. With Ecolab's strong balance sheet, the proceeds from this transaction enhance the company's ability to invest in attractive growth opportunities and return capital to shareholders. Therefore, the company announced its intent to repurchase up to an additional $500 million of Ecolab stock during the second half of 2024.
Posted In: ECL
